Boditech Med Balance Sheet Health
Financial Health criteria checks 6/6
Boditech Med has a total shareholder equity of ₩197.4B and total debt of ₩9.4B, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are ₩227.9B and ₩30.5B respectively. Boditech Med's EBIT is ₩28.3B making its interest coverage ratio -90.2. It has cash and short-term investments of ₩76.2B.
Key information
4.7%
Debt to equity ratio
₩9.36b
Debt
Interest coverage ratio | -90.2x |
Cash | ₩76.20b |
Equity | ₩197.42b |
Total liabilities | ₩30.49b |
Total assets | ₩227.90b |
Recent financial health updates
Recent updates
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth
Apr 16Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today
Apr 13Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?
Mar 01Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly
Jan 18Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock
Dec 28Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?
Dec 08Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 18Financial Position Analysis
Short Term Liabilities: A206640's short term assets (₩138.7B) exceed its short term liabilities (₩27.3B).
Long Term Liabilities: A206640's short term assets (₩138.7B) exceed its long term liabilities (₩3.2B).
Debt to Equity History and Analysis
Debt Level: A206640 has more cash than its total debt.
Reducing Debt: A206640's debt to equity ratio has reduced from 38.9% to 4.7% over the past 5 years.
Debt Coverage: A206640's debt is well covered by operating cash flow (366.5%).
Interest Coverage: A206640 earns more interest than it pays, so coverage of interest payments is not a concern.